Novanta (NOVT) Expected to Announce Earnings on Tuesday

Novanta (NASDAQ:NOVT) is expected to release its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect Novanta to post earnings of $0.88 per share and revenue of $260.7220 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 8:00 AM ET.

Novanta Price Performance

Shares of NOVT opened at $145.96 on Friday. The firm has a market capitalization of $5.22 billion, a price-to-earnings ratio of 99.29 and a beta of 1.62. The firm’s fifty day simple moving average is $131.69 and its 200-day simple moving average is $119.64. Novanta has a twelve month low of $98.27 and a twelve month high of $153.20. The company has a current ratio of 2.51, a quick ratio of 1.54 and a debt-to-equity ratio of 0.56.

Wall Street Analysts Forecast Growth

NOVT has been the topic of a number of analyst reports. Weiss Ratings upgraded Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Zacks Research raised Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $133.00.

Insider Activity

In other news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the transaction, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. This trade represents a 11.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction on Wednesday, January 21st. The shares were sold at an average price of $140.14, for a total transaction of $199,419.22. Following the completion of the sale, the chief financial officer owned 91,034 shares of the company’s stock, valued at approximately $12,757,504.76. This trade represents a 1.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 22,923 shares of company stock worth $3,182,264. Corporate insiders own 1.20% of the company’s stock.

Hedge Funds Weigh In On Novanta

Several institutional investors have recently bought and sold shares of the company. Schroder Investment Management Group increased its position in Novanta by 206.1% during the 4th quarter. Schroder Investment Management Group now owns 600,146 shares of the technology company’s stock worth $72,540,000 after purchasing an additional 404,097 shares during the period. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of Novanta by 217,908.2% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 346,633 shares of the technology company’s stock valued at $41,246,000 after buying an additional 346,474 shares in the last quarter. Wellington Management Group LLP grew its holdings in Novanta by 247.2% during the fourth quarter. Wellington Management Group LLP now owns 357,946 shares of the technology company’s stock worth $42,592,000 after acquiring an additional 254,860 shares during the period. American Capital Management Inc. purchased a new position in Novanta in the third quarter worth $21,919,000. Finally, Bamco Inc. NY raised its position in Novanta by 202.3% in the second quarter. Bamco Inc. NY now owns 311,115 shares of the technology company’s stock worth $40,112,000 after acquiring an additional 208,188 shares in the last quarter. 98.35% of the stock is owned by institutional investors and hedge funds.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.